Technology Ventures’ Inventor’s Spotlight: Bob Beitle
Over the course of his career, Beitle has achieved several milestones. In 1998, he was awarded tenure and promoted to the position of associate professor, followed by another promotion to the rank of professor and to his current position of senior associate vice chancellor for research and innovation. He currently holds the Jim L. Turpin Professorship in Chemical and Biochemical Separations. His ascent in academia is a testament to his exceptional dedication to research and teaching.
Bob Beitle is an active member of several professional organizations, including the American Institute of Chemical Engineers and the American Chemical Society (or ACS). Through his involvement in these societies, he has contributed to the advancement of biochemical engineering by sharing knowledge, exchanging ideas and collaborating with experts in the field.
One of Beitle’s primary research interests lies in the field of biochemical engineering, specifically in the areas of bioseparation and fermentation. Bioseparation refers to the process of separating biological materials from complex mixtures. This is a critical step in various biotechnological applications, including the production of pharmaceuticals, biofuels and enzymes.
His expertise in fermentation, on the other hand, has been instrumental in advancing the production of valuable compounds using microbial systems. Fermentation is a biological process where microorganisms, such as bacteria or yeast, are used to convert raw materials into useful products. This process has widespread applications in the production of enzymes, therapeutics, biofuels, antibiotics, and organic acids.
Among Beitle’s most recent achievements is a groundbreaking patent on LAMP PCR. Polymerase Chain Reaction (PCR) is a widely used technique in molecular biology to amplify specific DNA sequences. Loop-Mediated Isothermal Amplification (LAMP) is an emerging variant of PCR that enables the amplification of DNA at a constant temperature without the need for costly thermocyclers.
Beitle’s patent, unlike traditional PCR methods, does not require thermal cycling, which makes it faster, simpler, and more cost-effective. This technology has transformative implications for fields such as medical diagnostics, infectious disease detection, and genetic research. Its efficiency and accuracy have the potential to revolutionize various applications that rely on DNA amplification.
Beitle’s research group has graduated a significant number of students who are employed by large pharmaceutical companies like Pfizer, Briston-Myers-Squibb, Amgen, and BioGen Idec and reagent suppliers like Pel-Freez Biologicals in Rogers, Arkansas. His impressive journey from an ambitious graduate student to professor at the university has been marked by groundbreaking research, exemplary teaching, and a strong commitment to advancing the fields of biochemical engineering. As Beitle continues to inspire students and colleagues alike, it is clear that his dedication to advancing science and technology will leave a lasting legacy in the world of chemical engineering and beyond.
Nicole Wegrzyn, social media and marketing assistant
Technology Ventures
479-575-5932, nwegrzyn@uark.edu
